Tauopathies-focus on changes at the neurovascular unit

A Michalicova, WA Banks, J Legath… - Current Alzheimer …, 2017 - ingentaconnect.com
In the past, the blood-brain barrier (BBB) has been characterized mainly as a layer of
endothelial cells forming the vessel/capillary wall of the brain. More recently, the BBB is …

[HTML][HTML] Heparan sulfate subdomains that are degraded by Sulf accumulate in cerebral amyloid ß plaques of Alzheimer's disease: evidence from mouse models and …

T Hosono-Fukao, S Ohtake-Niimi, H Hoshino… - The American journal of …, 2012 - Elsevier
Alzheimer's disease (AD) is characterized by extracellular cerebral accumulation of amyloid
β peptide (Aβ). Heparan sulfate (HS) is a glycosaminoglycan that is abundant in the …

Plasma soluble neuregulin-1 as a diagnostic biomarker for Alzheimer's disease

KA Chang, KY Shin, E Nam, YB Lee, C Moon… - Neurochemistry …, 2016 - Elsevier
To identify some apparent biomarker candidates for the diagnosis of Alzheimer's disease
(AD) pathology, we investigated whether there would be a significant difference between the …

Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine

K Tsukuda, M Mogi, JM Li, J Iwanami, LJ Min… - …, 2008 - Am Heart Assoc
Nifedipine, a calcium channel blocker, has been reported to exert pleiotropic effects on
atherosclerosis, mainly through its antioxidative properties. However, the effect of the …

Differential distribution of neuregulin in human brain and spinal fluid

MS Pankonin, J Sohi, J Kamholz, JA Loeb - Brain research, 2009 - Elsevier
The neuregulins are a family of polypeptide factors implicated in a wide range of
neurological and psychiatric disorders including multiple sclerosis, schizophrenia, and …

Glycosaminoglycans and glycomimetics in the central nervous system

D Rowlands, K Sugahara, JCF Kwok - Molecules, 2015 - mdpi.com
With recent advances in the construction of synthetic glycans, selective targeting of the
extracellular matrix (ECM) as a potential treatment for a wide range of diseases has become …

Structural alterations at the neuromuscular junctions of matrix metalloproteinase 3 null mutant mice

M VanSaun, AA Herrera, MJ Werle - Journal of neurocytology, 2003 - Springer
Matrix metalloproteinases are important regulators of extracellular matrix molecules and cell-
cell signaling. Antibodies to matrix metalloproteinase 3 (MMP3) recognize molecules at the …

Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ‐on‐a‐Chip Technology

FM Pramotton, S Spitz, RD Kamm - Advanced Science, 2024 - Wiley Online Library
Neurodegenerative diseases (NDDs) affect more than 50 million people worldwide, posing
a significant global health challenge as well as a high socioeconomic burden. With aging …

Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma

E Batmunkh, P Tátrai, E Szabó, C Lódi, Á Holczbauer… - Human pathology, 2007 - Elsevier
Heparan sulfate proteoglycans mediate cell adhesion and control the activities of numerous
growth and motility factors. They play a critical role in carcinogenesis and tumor progression …

Heparan sulfate proteoglycans in amyloidosis

X Zhang, JP Li - Progress in molecular biology and translational …, 2010 - Elsevier
Amyloidosis is a generic term for a group of diseases characterized by deposits in different
organ systems of insoluble materials composed mainly of distinct fibrillar proteins named …